Upload Avatar (500 x 500)
Wang Biao
wangbiao@cmu.edu.cn
English, Chinese
Liaoning
China Medical University
Life Sciences
  • Doctorate: Not mentioned
  • Achievement: Deputy Head of the Art Group of the Education Branch of the Chinese Medical Association
  • Achievement: Standing Member of the Liaoning Traditional Chinese Medicine Evidence-Based Medicine Committee
  • Achievement: National Second-Level Psychological Counselor
  • 2019-2020 - Case Western Reserve University School of Medicine - Senior Visiting Scholar
Molecular mechanisms of tumor development and immune microenvironment
Bioinformatics and AI deep learning methods for screening molecular targets and small molecule drugs
  • TEAD4: A key regulator of tumor metastasis and chemoresistance -Mechanisms and therapeutic implications, Corresponding Author, 2024
  • Unraveling the molecular mechanisms of flavonoid biosynthesis in Panax notoginseng flowers across planting patterns and developmental stages using integrated metabolomics and transcriptomics analyses, Corresponding Author, 2024
  • Regulation of the tumor immune microenvironment by the Hippo Pathway: Implications for cancer immunotherapy, Corresponding Author, 2023
  • Potential roles of N6-methyladenosine (m6A) in immune cells, Corresponding Author, 2023
  • TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer, Corresponding Author, 2022
  • Immunotherapy checkpoints in ovarian cancer vasculogenic mimicry: Tumor immune microenvironments, and drugs, Corresponding Author, 2022
  • Comparative analysis of floral scent profiles between two Chimonanthus praecox plants under different rhythms and blooming stages, Corresponding Author, 2022
  • Metformin targets a YAP1-TEAD4 complex via AMPKα to regulate CCNE1/2 in bladder cancer cells, Corresponding Author, 2019
  • IL‐17A promotes cell migration and invasion of glioblastoma cells via activation of PI3K/AKT signaling pathway, Corresponding Author, 2019
Tumor Molecular Mechanisms Immune Microenvironment Bioinformatics Ai Deep Learning Molecular Targets Small Molecule Drugs Cancer Immunotherapy

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.